Medication risk management technology
Avendi Rx® was the first long-term care pharmacy in NC to provide genetic testing. Pharmacogenetic testing brings personalized drug-to-gene monitoring to identify at-risk residents—resulting in enhanced clinical outcomes, medication compliance, and reduced readmissions.
The key value of Avendi Rx®’s collaboration with MedTek21 is an added layer of resident safety amongst our partner homes.
Often times, the issues related to a resident’s unique genetic profile are reimbursable—making MedTek21’s pharmacogenetic testing a win-win by saving your facility time in finding the appropriate medication, by reducing readmissions and falls, and by leading to better patient and family satisfaction within your
Benefits to your facility
- Enhanced clinical outcomes
- Medication compliance
- Decrease in readmissions
- Reduced falls
Benefits to the resident
- Reduced medication adverse effects
- Improved medication adherence
- Fewer hospitalizations
- Increased patient safety
How does it work?
MedTek21 utilizes pharmacogenetic testing to bring personalized drug-to-gene monitoring to your most at-risk residents
The software works alongside existing medical record systems to continuously monitor and proactively identify residents for medication risk. Identified residents will complete a 30-second mouth swab. This pain-free process discovers, monitors, and manages issues that may pop up concerning patient medications. This means less trial and error as well as reduced medication risk. Learn more